About Diffinity Genomics
Diffinity Genomics is a company based in West Henrietta (United States) founded in 2005 was acquired by Chiral Technologies in August 2015.. Diffinity Genomics has raised $1.36 million across 9 funding rounds from investors including HHS, Chiral Technologies and Mass Medical Angels. Diffinity Genomics operates in a competitive market with competitors including DnaNudge, Purigen Biosystems, Stratec Biomedical, Synplogen and Advanced Analytical Technologies, among others.
- Headquarter West Henrietta, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.36 M (USD)
in 9 rounds
-
Latest Funding Round
$99.65 K (USD), Grant
Aug 15, 2012
-
Investors
HHS
& 2 more
-
Employee Count
Employee Count
-
Acquired by
Chiral Technologies
(Aug 03, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Diffinity Genomics
Diffinity Genomics has successfully raised a total of $1.36M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $99.65 thousand completed in August 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Grant — $99,647
-
First Round
First Round
(25 Apr 2008)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2012 | Amount | Grant - Diffinity Genomics | Valuation |
investors |
|
| Jun, 2012 | Amount | Series B - Diffinity Genomics | Valuation |
investors |
|
| Mar, 2012 | Amount | Seed - Diffinity Genomics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Diffinity Genomics
Diffinity Genomics has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Chiral Technologies and Mass Medical Angels. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed stage investments are made in life sciences and healthcare.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Advanced chirality products and custom purification services
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Diffinity Genomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Diffinity Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Diffinity Genomics Comparisons
Competitors of Diffinity Genomics
Diffinity Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DnaNudge, Purigen Biosystems, Stratec Biomedical, Synplogen and Advanced Analytical Technologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Lab-on-chip wearable systems for genetic diagnosis are provided.
|
|
| domain | founded_year | HQ Location |
Isotachophoresis technology is provided for nucleic acid sample preparation.
|
|
| domain | founded_year | HQ Location |
Provider of automated analyzer systems, data management software, and solutions for IVD sample preparation
|
|
| domain | founded_year | HQ Location |
DNA synthesis technology is developed using microbial methods.
|
|
| domain | founded_year | HQ Location |
Instruments, software, and services for scientific laboratory management are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Diffinity Genomics
When was Diffinity Genomics founded?
Diffinity Genomics was founded in 2005 and raised its 1st funding round 3 years after it was founded.
Where is Diffinity Genomics located?
Diffinity Genomics is headquartered in West Henrietta, United States. It is registered at West Henrietta, New York, United States.
Is Diffinity Genomics a funded company?
Diffinity Genomics is a funded company, having raised a total of $1.36M across 9 funding rounds to date. The company's 1st funding round was a Seed of $678.26K, raised on Apr 25, 2008.
What does Diffinity Genomics do?
Diffinity Genomics was founded in 2005 and is based in West Henrietta, United States. Operations are centered in the genomics sector, where tools and methods for DNA amplification and analysis are provided. Services support research in molecular biology, with products accessible via diffinitygenomics.com. The focus remains on practical applications for scientific and diagnostic workflows in biotechnology.
Who are the top competitors of Diffinity Genomics?
Diffinity Genomics's top competitors include Stratec Biomedical, Purigen Biosystems and Advanced Analytical Technologies.
Who are Diffinity Genomics's investors?
Diffinity Genomics has 3 investors. Key investors include HHS, Chiral Technologies, and Mass Medical Angels.